Forte Biosciences, Inc.

SecurityFBRX / Forte Biosciences, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership2,312 shares
Latest Disclosed Value $ 59,880
Simplex Trading, Llc ownership in FBRX / Forte Biosciences, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 2,312 shares of Forte Biosciences, Inc. (US:FBRX) valued at $59,881 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 6,015 shares of Forte Biosciences, Inc.. This represents a change in shares of -61.56% during the quarter. The current value of the position is $38,587 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (FBRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FBRX / Forte Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F FORTE BIOSCIENCES COM 34962G208 2,312 -3,703 -61.56 60 -64.02 0.0000
2026-02-11 2025-12-31 13F FORTE BIOSCIENCES COM 34962G208 6,015 6,015 164 0.0001
2020-07-13 2020-06-30 13F TOCAGEN COM 888846102 0 -600 -100.00 0 0.0000
2020-04-29 2020-03-31 13F TOCAGEN COM 888846102 600 -2,538 -80.88 0 -100.00
2020-02-05 2019-12-31 13F TOCAGEN COM 888846102 3,138 -700 -18.24 1 -50.00 0.0000
2019-10-15 2019-09-30 13F TOCAGEN COM 888846102 3,838 -2,382 -38.30 2 -95.12 0.0000
2019-07-26 2019-06-30 13F TOCAGEN COM 888846102 6,220 -11,049 -63.98 41 -78.07 0.0001
2019-04-18 2019-03-31 13F TOCAGEN COM 888846102 17,269 13,236 328.19 187 466.67 0.0005
2019-01-16 2018-12-31 13F TOCAGEN COM 888846102 4,033 2,582 177.95 33 50.00 0.0001
2018-10-23 2018-09-30 13F TOCAGEN COM 888846102 1,451 1,451 22 0.0001
2018-04-26 2018-03-31 13F TOCAGEN COM 888846102 0 -904 -100.00 0 -100.00
2018-01-10 2017-12-31 13F TOCAGEN COM 888846102 904 904 9 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-04-25 2024-03-31 13F FORTE BIOSCIENCES CALL Call 0 -100.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F FORTE BIOSCIENCES CALL Call 15,400 -18.09 0 n/a n/a n/a
2023-11-01 2023-09-30 13F FORTE BIOSCIENCES CALL Call 18,800 21.29 0 n/a n/a n/a
2023-08-04 2023-06-30 13F FORTE BIOSCIENCES CALL Call 15,500 4.73 0 n/a n/a n/a
2023-04-27 2023-03-31 13F FORTE BIOSCIENCES CALL Call 14,800 -66.44 0 n/a n/a n/a
2023-02-02 2022-12-31 13F FORTE BIOSCIENCES CALL Call 44,100 -1.12 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F FORTE BIOSCIENCES CALL Call 44,600 27.43 47 4.44 n/a n/a n/a
2022-08-03 2022-06-30 13F FORTE BIOSCIENCES CALL Call 35,000 -4.89 45 -15.09 n/a n/a n/a
2022-05-02 2022-03-31 13F FORTE BIOSCIENCES CALL Call 36,800 -27.27 53 -50.93 n/a n/a n/a
2022-02-23 2021-12-31 13F/A FORTE BIOSCIENCES CALL Call 50,600 108 n/a n/a n/a
2020-10-14 2020-09-30 13F FORTE BIOSCIENCES CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F FORTE BIOSCIENCES CALL Call 4 -93.75 5 -28.57 n/a n/a n/a
2020-04-29 2020-03-31 13F TOCAGEN CALL Call 64 100.00 7 600.00 n/a n/a n/a
2020-02-05 2019-12-31 13F TOCAGEN CALL Call 32 -85.71 1 -92.86 n/a n/a n/a
2019-10-15 2019-09-30 13F TOCAGEN CALL Call 224 234.33 14 -68.18 n/a n/a n/a
2019-07-26 2019-06-30 13F TOCAGEN CALL Call 67 19.64 44 -26.67 n/a n/a n/a
2019-04-18 2019-03-31 13F TOCAGEN CALL Call 56 460.00 60 650.00 n/a n/a n/a
2019-01-16 2018-12-31 13F TOCAGEN CALL Call 10 -23.08 8 -60.00 n/a n/a n/a
2018-10-23 2018-09-30 13F TOCAGEN CALL Call 13 -88.29 20 -80.58 n/a n/a n/a
2018-07-30 2018-06-30 13F TOCAGEN CALL Call 111 484.21 103 n/a n/a n/a
2018-04-26 2018-03-31 13F TOCAGEN CALL Call 19 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-04-27 2023-03-31 13F FORTE BIOSCIENCES PUT Put 0 -100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F FORTE BIOSCIENCES PUT Put 400 -55.56 0 n/a n/a n/a
2022-11-04 2022-09-30 13F FORTE BIOSCIENCES PUT Put 900 -10.00 0 -100.00 n/a n/a n/a
2022-08-03 2022-06-30 13F FORTE BIOSCIENCES PUT Put 1,000 11.11 1 0.00 n/a n/a n/a
2022-05-02 2022-03-31 13F FORTE BIOSCIENCES PUT Put 900 -78.05 1 -87.50 n/a n/a n/a
2022-02-23 2021-12-31 13F/A FORTE BIOSCIENCES PUT Put 4,100 8 n/a n/a n/a
2020-07-13 2020-06-30 13F TOCAGEN PUT Put 0 -100.00 0 n/a n/a n/a
2020-04-29 2020-03-31 13F TOCAGEN PUT Put 6 100.00 0 n/a n/a n/a
2020-02-05 2019-12-31 13F TOCAGEN PUT Put 3 -98.96 0 -100.00 n/a n/a n/a
2019-10-15 2019-09-30 13F TOCAGEN PUT Put 289 7.43 19 -89.39 n/a n/a n/a
2019-07-26 2019-06-30 13F TOCAGEN PUT Put 269 249.35 179 115.66 n/a n/a n/a
2019-04-18 2019-03-31 13F TOCAGEN PUT Put 77 1,440.00 83 1,975.00 n/a n/a n/a
2019-01-16 2018-12-31 13F TOCAGEN PUT Put 5 0.00 4 -42.86 n/a n/a n/a
2018-10-23 2018-09-30 13F TOCAGEN PUT Put 5 7 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.